Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
thrombospondin-1 mimetic (ABT-510)
i
Other names:
ABT-510
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
AbbVie
Drug class:
Angiogenesis inhibitor, VEGF inhibitor, Hepatocyte growth factor inhibitor, FGF inhibitor, IL-8 inhibitor
Related drugs:
‹
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
TL-118 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
sonepcizumab (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
recombinant human endostatin (5)
ivonescimab (3)
BI 836880 (0)
autologous activated lymphocytes (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
CU06 (0)
AV-299 (2)
K-252a (1)
MP0250 (0)
YYB-101 (0)
AMY109 (0)
BMS-986253 (0)
DF-2156A (0)
DF 1681Y (0)
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
TL-118 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
sonepcizumab (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
recombinant human endostatin (5)
ivonescimab (3)
BI 836880 (0)
autologous activated lymphocytes (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
CU06 (0)
AV-299 (2)
K-252a (1)
MP0250 (0)
YYB-101 (0)
AMY109 (0)
BMS-986253 (0)
DF-2156A (0)
DF 1681Y (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.